Pseudomonas oryzihabitans
Pseudomonas oryzihabitans is a Gram-negative, aerobic, rod-shaped bacterium from the genus of Pseudomonas. It was first isolated from the roots of a rice plant, hence the name "oryzihabitans" which means "rice dweller". This bacterium is known to be a rare cause of human infection, but can be a potential pathogen in immunocompromised individuals.
Taxonomy[edit]
The bacterium belongs to the Pseudomonas genus, which is a diverse genus of bacteria. The species name, oryzihabitans, is derived from the Latin oryza (rice) and habitans (inhabiting), referring to the environment from which it was first isolated.
Characteristics[edit]
Pseudomonas oryzihabitans is a Gram-negative, aerobic, rod-shaped bacterium. It is motile due to the presence of a single flagellum. The bacterium is also capable of biofilm formation, which may contribute to its pathogenicity.
Pathogenicity[edit]
While Pseudomonas oryzihabitans is generally considered a low-virulence organism, it can cause infections in humans, particularly in those with compromised immune systems. It has been associated with a variety of infections, including bacteremia, endocarditis, meningitis, and peritonitis. The bacterium is resistant to many common antibiotics, making infections difficult to treat.
Treatment[edit]
Treatment of Pseudomonas oryzihabitans infections typically involves the use of antibiotics. However, the bacterium is known to be resistant to many common antibiotics, including penicillin and cephalosporin. Therefore, susceptibility testing is often necessary to determine the most effective treatment.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian